(Q33649891)

28 July 2017

1 reference

title

Reduction of circulating cholesterol and apolipoprotein levels during sepsis (English)

1 reference

28 July 2017

0 references

P Fraunberger

1

1 reference

28 July 2017

S Schaefer

2

1 reference

28 July 2017

K Werdan

3

1 reference

28 July 2017

A K Walli

4

1 reference

28 July 2017

D Seidel

5

1 reference

28 July 2017

publication date

1 March 1999

1 reference

Clinical Chemistry and Laboratory Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

37

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

357-362

1 reference

Changes in serum lipoprotein pattern induced by acute infections

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Platelet-derived growth factor stimulates activity of low density lipoprotein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Transforming growth factor-beta 1 and interleukin-1 beta stimulate LDL receptor activity in Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Triglyceride-rich lipoproteins prevent septic death in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.059

21 January 2018

Identifiers

DOI

10.1515/CCLM.1999.059

1 reference

28 July 2017

1 reference